Lentiviral vectors: basic to translational.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochemical Journal

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ20120146PMID 22507128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma

  2011cited by this paper
• A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1–derived lentiviral vectors

  2011cited by this paper
• Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation

  2011cited by this paper
• Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells

  2011cited by this paper
• In vitro and in vivo comparison of viral and cellular internal ribosome entry sites for bicistronic vector expression

  2011cited by this paper
• SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

  2011cited by this paper
• Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector

  2011cited by this paper
• Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors

  2011cited by this paper
• Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.

  2011cited by this paper
• In Vivo Imaging of Ligand Receptor Binding with Gaussia Luciferase Complementation

  2011cited by this paper
• Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells

  2011cited by this paper
• Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.

  2011cited by this paper
• Development of an All-in-One Lentiviral Vector System Based on the Original TetR for the Easy Generation of Tet-ON Cell Lines

  2011cited by this paper
• Antiviral restriction factor transgenesis in the domestic cat

  2011cited by this paper
• Efficacy of gene therapy for X-linked severe combined immunodeficiency.

  2010cited by this paper
• HIV virology and pathogenetic mechanisms of infection: a brief overview.

  2010cited by this paper
• A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.

  2010cited by this paper
• Lymphomagenesis in SCID-X1 Mice Following Lentivirus-mediated Phenotype Correction Independent of Insertional Mutagenesis and γc Overexpression.

  2010cited by this paper
• An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.

  2010cited by this paper
• Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.

  2010cited by this paper
• Characterization of Retroviral and Lentiviral Vectors Pseudotyped with Xenotropic Murine Leukemia Virus-Related Virus Envelope Glycoprotein

  2010cited by this paper
• Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

  2010cited by this paper
• Nonintegrating Lentiviral Vectors Can Effectively Deliver Ovalbumin Antigen for Induction of Antitumor Immunity

  2009cited by this paper
• Conditional expression of genes in the respiratory epithelium in transgenic mice: cautionary notes and toward building a better mouse trap.

  2009cited by this paper
• Lentiviral Vector Design for Optimal T Cell Receptor Gene Expression in the Transduction of Peripheral Blood Lymphocytes and Tumor-Infiltrating Lymphocytes

  2009cited by this paper
• rtTA toxicity limits the usefulness of the SP-C-rtTA transgenic mouse.

  2009cited by this paper
• The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.

  2009cited by this paper
• Lentiviral tracking of vascular differentiation in bone marrow progenitor cells.

  2009cited by this paper
• Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

  2009cited by this paper
• Highly Efficient Multicistronic Lentiviral Vectors with Peptide 2A Sequences

  2009cited by this paper
• Stable knockdown of microRNA in vivo by lentiviral vectors

  2009cited by this paper
• HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells

  2009cited by this paper
• Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

  2009cited by this paper
• Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection.

  2009cited by this paper
• Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors.

  2009cited by this paper
• Maturation of the HIV reverse transcription complex: putting the jigsaw together

  2009cited by this paper
• Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV‐1 vectors

  2009cited by this paper
• Reprogramming of murine and human somatic cells using a single polycistronic vector

  2009cited by this paper
• Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS

  2009cited by this paper
• Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition

  2008cited by this paper
• Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats

  2008cited by this paper
• Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.

  2008cited by this paper
• A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells

  2008cited by this paper
• Inhibition of Lassa and Marburg Virus Production by Tetherin

  2008cited by this paper
• Applications of lentiviral vectors for shRNA delivery and transgenesis.

  2008cited by this paper
• Targeted cell entry of lentiviral vectors.

  2008cited by this paper
• Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

  2008cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Improved Human β-globin Expression from Self-inactivating Lentiviral Vectors Carrying the Chicken Hypersensitive Site-4 (cHS4) Insulator Element.

  2007cited by this paper
• An improved zinc-finger nuclease architecture for highly specific genome editing

  2007cited by this paper
• Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8+ and CD4+ T-Cell Responses

  2007cited by this paper
• Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency.

  2007cited by this paper
• Extended Core Sequences from the cHS4 Insulator Are Necessary for Protecting Retroviral Vectors from Silencing Position Effects

  2007cited by this paper
• Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.

  2007cited by this paper
• Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells

  2007cited by this paper
• Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo.

  2007cited by this paper
• Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft

  2007cited by this paper
• Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element.

  2007cited by this paper
• Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters

  2007cited by this paper
• Stable gene transfer to muscle using non-integrating lentiviral vectors.

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

  2007cited by this paper
• A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice.

  2007cited by this paper
• Gene therapy: Therapeutic gene causing lymphoma

  2006cited by this paper
• Effective gene therapy with nonintegrating lentiviral vectors

  2006cited by this paper
• A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors.

  2006cited by this paper
• Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo

  2006cited by this paper
• Gene transfer in humans using a conditionally replicating lentiviral vector

  2006cited by this paper
• Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging.

  2006cited by this paper
• Comparison of lentiviral vector titration methods

  2006cited by this paper
• Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus

  2006cited by this paper
• Tubulovesicular Structures within Vesicular Stomatitis Virus G Protein-Pseudotyped Lentiviral Vector Preparations Carry DNA and Stimulate Antiviral Responses via Toll-Like Receptor 9

  2006cited by this paper
• Targeting lentiviral vectors to specific cell types in vivo.

  2006cited by this paper
• An Essential Role for LEDGF/p75 in HIV Integration

  2006cited by this paper
• Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

  2006cited by this paper
• Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.

  2006cited by this paper
• Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

  2006cited by this paper
• Transient gene expression by nonintegrating lentiviral vectors.

  2006cited by this paper
• Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells.

  2005cited by this paper
• In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.

  2005cited by this paper
• Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters

  2005cited by this paper
• Successful Correction of the Human Cooley's Anemia β‐Thalassemia Major Phenotype Using a Lentiviral Vector Flanked by the Chicken Hypersensitive Site 4 Chromatin Insulator

  2005cited by this paper
• Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.

  2005cited by this paper
• Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 Vectors with Alphavirus Envelope Glycoproteins Produced from Stable Packaging Cells

  2005cited by this paper
• Restriction of Feline Immunodeficiency Virus by Ref1, Lv1, and Primate TRIM5α Proteins

  2005cited by this paper
• A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia

  2005cited by this paper
• Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS

  2005cited by this paper
• Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection

  2005cited by this paper
• Stable transduction of primary human monocytes by simian lentiviral vector PBj.

  2005cited by this paper
• Generation of a packaging cell line for prolonged large‐scale production of high‐titer HIV‐1‐based lentiviral vector

  2005cited by this paper
• Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)

  2005cited by this paper
• A role for LEDGF/p75 in targeting HIV DNA integration

  2005cited by this paper
• A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.

  2005cited by this paper
• Regulatory Considerations for Novel Gene Therapy Products: A Review of the Process Leading to the First Clinical Lentiviral Vector

  2005cited by this paper
• Safe two‐plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one‐step protocol

  2004cited by this paper
• Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells

  2004cited by this paper
• Capsid-Dependent and -Independent Postentry Restriction of Primate Lentivirus Tropism in Rodent Cells

  2004cited by this paper
• Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

  2004cited by this paper
• Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector

  2004cited by this paper

• Inhibition of the SGLT2/NHE-1/NLRP3 Signaling Axis Attenuates Neuroinflammation and Oxidative Stress to Ameliorate Seizures and Cognitive Impairment in Epileptic Mice.

  2026cites this paper
• Targeted demethylation of the BRD7 promoter based on CRISPR/dCas9 system inhibits the malignant progression of nasopharyngeal carcinoma

  2026cites this paper
• Efficiency of Lentiviral Vectors Pseudotyped with LCMV-G in Gene Transfer to Ldlr−/−ApoB100/100 Mice

  2026cites this paper
• Lentiviral Vector-Mediated Gene Delivery for iPSC-Related Neuroscience Research.

  2026cites this paper
• Preparation of Lentiviral Vectors for the Generation of Transgenic Cynomolgus Monkeys.

  2026cites this paper
• Advanced gene therapy in Parkinson’s disease through innovations in drug delivery systems

  2025cites this paper
• Hurdles to healing: Overcoming cellular barriers for viral and nonviral gene therapy.

  2025cites this paper
• Hypoxia and HIF-1 inhibition enhance lentiviral transduction efficiency: a novel strategy for gene delivery optimization

  2025cites this paper
• Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects.

  2025cites this paper
• Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics.

  2025cites this paper
• A study on the production of extracellular vesicles derived from novel immortalized human placental mesenchymal stromal cells

  2025influential citation
• Targeting immune heterogeneity in liver metastases through in vivo genetic engineering.

  2025cites this paper
• Progress in Pseudotyping Lentiviral Vectors Towards Cell-Specific Gene Delivery In Vivo

  2025cites this paper
• Proteostasis and pathogenesis: Unraveling the complexity of protein misfolding disorders.

  2025cites this paper
• Transgene integration in mammalian cells: The tools, the challenges, and the future.

  2025cites this paper
• An HRL-SC/HIF-1α positive feedback loop enhances cell proliferation, migration and angiogenesis in dental pulp stem cells via PI3K/AKT signalling pathway.

  2025cites this paper
• Development of a novel pseudovirus-based quality control material for HIV-1 nucleic acid testing and its application in external quality assessment

  2025cites this paper
• Unraveling Botulinum Neurotoxin A Light-Chain-Induced Signaling Pathways: A Phosphoproteomic Analysis in a Controlled Cellular Model

  2025cites this paper
• Lentiviral Vectors: From Wild-Type Viruses to Efficient Multi-Functional Delivery Vectors

  2025influential citation
• Stable production of immortalized hPC-MSC-derived extracellular vesicles: integrated cargo analysis and functional validation

  2025influential citation
• Gene therapy for genetic diseases: challenges and future directions

  2025cites this paper
• Deciphering key parameters enhancing lentiviral vector producer cells yields: Vector components copy number and expression

  2025cites this paper
• Gag ubiquitination facilitates ALIX-mediated lentiviral RNA packaging, counteracted by USP8

  2025cites this paper
• IFN‐γ‐Induced CD317 Tethers Extracellular Vesicles to Mesenchymal Stromal Cells Interfering With Immune Modulation

  2025cites this paper
• Vesicular Stomatitis Virus Glycoprotein- and Lentiviral RNA-Based Robust Approach for Rapid and Accurate Quantification of Viable Lentiviral Vectors.

  2025cites this paper
• Modeling Alzheimer’s Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling

  2025cites this paper
• Viral-based gene therapy clinical trials for immune deficiencies and blood disorders from 2013 until 2023 - an overview

  2024cites this paper
• Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture

  2024cites this paper
• One-Step Genetic Modification by Embryonic Doral Aorta Injection of Adenoviral CRISPR/Cas9 Vector in Chicken

  2024cites this paper
• Cell-based assay to detect small molecules restoring levels of let-7 miRNAs.

  2024cites this paper
• Current developments of gene therapy in human diseases

  2024cites this paper
• Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives

  2024cites this paper
• Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector production

  2024cites this paper
• Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing

  2024cites this paper
• Use of Lentivirus‐Based Method for Establishing TK6 Human Cell Lines Expressing Cytochrome P450 and its Applications in Genotoxicity Testing

  2024cites this paper
• Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing

  2024cites this paper
• Preamplification-free viral RNA diagnostics with single-nucleotide resolution using MARVE, an origami paper-based colorimetric nucleic acid test

  2024cites this paper
• Adapted methods for monitoring influenza virus and respiratory syncytial virus in sludge and wastewater.

  2024cites this paper
• In Situ Cellular Reprogramming: A Novel Targeting of Parkinson’s Disease

  2024cites this paper
• Analyzing efficiency of a lentiviral shRNA knockdown system in human enteroids using western blot and flow cytometry

  2024cites this paper
• Comparison of two methods of sperm- and testis-mediated gene transfer in production of transgenic animals: A systematic review.

  2024cites this paper
• Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders

  2023cites this paper
• Characterization of a new IN-I-PpoI fusion protein and a homology-arm containing transgene cassette that improve transgene expression persistence and 28S rRNA gene-targeted insertion of lentiviral vectors

  2023cites this paper
• Visualizing the Nucleome Using the CRISPR–Cas9 System: From in vitro to in vivo

  2023cites this paper
• Challenges and new technologies in adoptive cell therapy

  2023cites this paper
• Advanced approaches to overcome biological barriers in respiratory and systemic routes of administration for enhanced nucleic acid delivery to the lung

  2023cites this paper
• Standardization Approaches for Extracellular Vesicle Loading with Oligonucleotides and Biologics.

  2023cites this paper
• Insights into product and process related challenges of lentiviral vector bioprocessing

  2023cites this paper
• Monitoring influenza and respiratory syncytial virus in wastewater. Beyond COVID-19

  2023cites this paper
• Viral Vector-Based Gene Therapy

  2023cites this paper
• Targeted DNA Demethylation: Vectors, Effectors and Perspectives

  2023cites this paper
• Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide.

  2023cites this paper
• OPTO-BLUE: An Integrated Bidirectional Optogenetic Lentiviral Platform for Controlled Light-Induced Gene Expression

  2023cites this paper
• Innovative approaches in transforming microRNAs into therapeutic tools

  2022cites this paper
• Therapeutic Potential of Combinative shRNA-Encoded Lentivirus-Mediated Gene Silencing to Accelerate Somatosensory Recovery After Spinal Cord Trauma

  2022cites this paper
• Update on Viral Gene Therapy Clinical Trials for Retinal Diseases

  2022cites this paper
• Episomes and Transposases—Utilities to Maintain Transgene Expression from Nonviral Vectors

  2022cites this paper
• Integrase deficient lentiviral vector: prospects for safe clinical applications

  2022cites this paper
• Over-Expression of Two Different Isoforms of Cattle TUSC5 Showed Opposite Effects on Adipogenesis

  2022cites this paper
• Cell Reprogramming for Regeneration and Repair of the Nervous System

  2022influential citation
• Rapid, accurate mapping of transgene integration in viable rhesus macaque embryos using enhanced-specificity tagmentation-assisted PCR

  2022cites this paper
• Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders

  2022cites this paper
• Computational analysis of 4-1BB-induced NFκB signaling suggests improvements to CAR cell design

  2022cites this paper
• Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave

  2022cites this paper
• Genetic therapeutic advancements for Dravet Syndrome.

  2022cites this paper
• Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins

  2022cites this paper
• Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?

  2022cites this paper
• Gene therapy: Comprehensive overview and therapeutic applications.

  2022cites this paper
• Role of Apoptosis in HIV Pathogenesis

  2022cites this paper
• SUN2 Modulates the Propagation of HSV-1

  2022cites this paper
• Aberrant splicing events caused by insertion of genes of interest into expression vectors

  2022cites this paper
• Delivery of Genetic Information: Viral Vector and Nonviral Vector Gene Therapies

  2021cites this paper
• Gene Therapy for Mucopolysaccharidosis Type II—A Review of the Current Possibilities

  2021cites this paper
• Gene Therapy for Sickle Cell Disease - Moving from the Bench to the Bedside.

  2021cites this paper
• DNA- and RNA-based Gene Therapies in Ophthalmology

  2021cites this paper
• Probing Synaptic Signaling with Optogenetic Stimulation and Genetically Encoded Calcium Reporters.

  2021cites this paper
• Targeted genome editing for the correction or alleviation of primary Immunodeficiencies.

  2021cites this paper
• Gene therapy in the anterior eye segment.

  2021cites this paper
• Retrograde Axonal Transport Property of Adeno-Associated Virus and Its Possible Application in Future.

  2021cites this paper
• CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals.

  2021cites this paper
• Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning

  2021cites this paper
• More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation

  2021cites this paper
• Mechanisms underlying reproductive toxicity induced by nickel nanoparticles identified by comprehensive gene expression analysis in GC-1 spg cells.

  2021cites this paper
• Lentiviral vector-mediated expression of C3 transferase attenuates retinal ischemia and reperfusion injury in rats.

  2021cites this paper
• The Engineered MARCH8-Resistant Vesicular Stomatitis Virus Glycoprotein Enhances Lentiviral Vector Transduction

  2021cites this paper
• Genetic Delivery and Gene Therapy in Pulmonary Hypertension

  2021cites this paper
• IL‐10 lentivirus‐laden hydrogel tubes increase spinal progenitor survival and neuronal differentiation after spinal cord injury

  2021cites this paper
• Lentiviral Transduction for Optimal LSC/HSC Manipulation.

  2021cites this paper
• A novel role for gag as a cis-acting element regulating RNA structure, dimerization and packaging in HIV-1 lentiviral vectors

  2021influential citation
• Lentiviral Transduction of Neuronal Cells.

  2021cites this paper
• Viral vectors as a promising nanotherapeutic approach against neurodegenerative disorders

  2021cites this paper
• Tagging and Capturing of Lentiviral Vectors Using Short RNAs

  2021cites this paper
• Advances in gene therapy for neurogenetic diseases: a brief review

  2021influential citation
• Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent

  2020cites this paper
• Progress and Perspectives in the Development of Lentiviral Vector Producer Cells

  2020cites this paper
• A tool with many applications: vesicular stomatitis virus in research and medicine

  2020cites this paper
• Viruses, the vehicle for cancer gene therapy: A Review

  2020cites this paper
• Gene regulations and delivery vectors for treatment of cancer

  2020cites this paper
• Diving into the brain: deep-brain imaging techniques in conscious animals

  2020cites this paper
• Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations

  2020cites this paper